Sustained Release Excipients - Global Strategic Business Report

Global Sustained Release Excipients Market to Reach $2.1 Billion by 2030

The global market for Sustained Release Excipients estimated at US$1.3 Billion in the year 2022, is projected to reach a revised size of US$2.1 Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2022-2030. Polymers, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sugars segment is readjusted to a revised 5.8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $369.1 Million, While China is Forecast to Grow at 6.3% CAGR

The Sustained Release Excipients market in the U.S. is estimated at US$369.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$370.1 Million by the year 2030 trailing a CAGR of 6.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Select Competitors (Total 43 Featured) -

• Alkermes plc
• Allergan plc
• Aradigm Corporation
• AstraZeneca
• Capsugel
• Coating Place, Inc.
• Corium International, Inc.
• Depomed, Inc.
• GlaxoSmithKline plc
• Janssen Pharmaceuticals, Inc.
• Mayne Pharma Group Limited
• Mylan N.V.
• Novartis AG
• Orbis Biosciences, Inc.
• Pfizer, Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Valeant Pharmaceuticals International, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year